Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Rando

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Antimicrobial Agents and Chemotherapy|August 3, 1999
Anti-human immunodeficiency virus type 1 activity, intracellular metabolism, and pharmacokinetic evaluation of 2'-deoxy-3'-oxa-4'-thiocytidineJ M de Muys, H Gourdeau, N Nguyen-Ba, et al.
Molecular Pharmacology|March 14, 1998
Human immunodeficiency virus glycoprotein gp120 as the primary target for the antiviral action of AR177 (Zintevir)J A Esté, C Cabrera, D Schols, et al.
Antiviral Chemistry & Chemotherapy|January 6, 1999
Thiazolo[4,5-d]pyrimidines. Part II. Synthesis and anti-human cytomegalovirus activity in vitro of certain acyclonucleosides and acyclonucleotides derived from the guanine analogue 5-aminothiazolo[4,5-d]pyrimidine-2,7(3H,6H)-dioneG R Revankar, J O Ojwang, S D Mustain, et al.
Antiviral Chemistry & Chemotherapy|May 21, 1999
Pyrido [1,2a] indole derivatives identified as novel non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1D L Taylor, P S Ahmed, P Chambers, et al.
Antiviral Chemistry & Chemotherapy|August 19, 2000
Drug resistance and drug combination features of the human immunodeficiency virus inhibitor, BCH-10652 [(+/-)-2'-deoxy-3'-oxa-4'-thiocytidine, dOTC]D L Taylor, P S Ahmed, A S Tyms, et al.
Nutricion Hospitalaria|May 9, 2012
[Gastrocolocutaneous fistula: an uncommon complication of percutaneous endoscopic gastrostomy]J M Ruiz Ruiz, J F Rando Muñoz, P Salvá Villar, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2000
Antiviral activity of 2'-deoxy-3'-oxa-4'-thiocytidine (BCH-10652) against lamivudine-resistant human immunodeficiency virus type 1 in SCID-hu Thy/Liv miceC A Stoddart, M E Moreno, V D Linquist-Stepps, et al.
Biochemistry|May 20, 1997
Modified antisense oligonucleotides directed against tumor necrosis factor receptor type I inhibit tumor necrosis factor alpha-mediated functionsJ O Ojwang, S D Mustain, H B Marshall, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Antimicrobial Agents and Chemotherapy|August 3, 1999
Anti-human immunodeficiency virus type 1 activity, intracellular metabolism, and pharmacokinetic evaluation of 2'-deoxy-3'-oxa-4'-thiocytidineJ M de Muys, H Gourdeau, N Nguyen-Ba, et al.
Molecular Pharmacology|March 14, 1998
Human immunodeficiency virus glycoprotein gp120 as the primary target for the antiviral action of AR177 (Zintevir)J A Esté, C Cabrera, D Schols, et al.
Antiviral Chemistry & Chemotherapy|January 6, 1999
Thiazolo[4,5-d]pyrimidines. Part II. Synthesis and anti-human cytomegalovirus activity in vitro of certain acyclonucleosides and acyclonucleotides derived from the guanine analogue 5-aminothiazolo[4,5-d]pyrimidine-2,7(3H,6H)-dioneG R Revankar, J O Ojwang, S D Mustain, et al.
Antiviral Chemistry & Chemotherapy|May 21, 1999
Pyrido [1,2a] indole derivatives identified as novel non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1D L Taylor, P S Ahmed, P Chambers, et al.
Antiviral Chemistry & Chemotherapy|August 19, 2000
Drug resistance and drug combination features of the human immunodeficiency virus inhibitor, BCH-10652 [(+/-)-2'-deoxy-3'-oxa-4'-thiocytidine, dOTC]D L Taylor, P S Ahmed, A S Tyms, et al.
Nutricion Hospitalaria|May 9, 2012
[Gastrocolocutaneous fistula: an uncommon complication of percutaneous endoscopic gastrostomy]J M Ruiz Ruiz, J F Rando Muñoz, P Salvá Villar, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2000
Antiviral activity of 2'-deoxy-3'-oxa-4'-thiocytidine (BCH-10652) against lamivudine-resistant human immunodeficiency virus type 1 in SCID-hu Thy/Liv miceC A Stoddart, M E Moreno, V D Linquist-Stepps, et al.
Biochemistry|May 20, 1997
Modified antisense oligonucleotides directed against tumor necrosis factor receptor type I inhibit tumor necrosis factor alpha-mediated functionsJ O Ojwang, S D Mustain, H B Marshall, et al.
Pageof 7